179 related articles for article (PubMed ID: 22340062)
41. Neonatal and maternal outcome after blastocyst transfer: a population-based registry study.
Ginström Ernstad E; Bergh C; Khatibi A; Källén KB; Westlander G; Nilsson S; Wennerholm UB
Am J Obstet Gynecol; 2016 Mar; 214(3):378.e1-378.e10. PubMed ID: 26928152
[TBL] [Abstract][Full Text] [Related]
42. Kidney disease and maternal and fetal outcomes in pregnancy.
Kendrick J; Sharma S; Holmen J; Palit S; Nuccio E; Chonchol M
Am J Kidney Dis; 2015 Jul; 66(1):55-9. PubMed ID: 25600490
[TBL] [Abstract][Full Text] [Related]
43. Increased risk of adverse pregnancy outcomes for women with migraines: a nationwide population-based study.
Chen HM; Chen SF; Chen YH; Lin HC
Cephalalgia; 2010 Apr; 30(4):433-8. PubMed ID: 19614685
[TBL] [Abstract][Full Text] [Related]
44. Perinatal outcomes in women living with HIV-1 and receiving antiretroviral therapy-a systematic review and meta-analysis.
Shinar S; Agrawal S; Ryu M; Walmsley S; Serghides L; Yudin MH; Murphy KE
Acta Obstet Gynecol Scand; 2022 Feb; 101(2):168-182. PubMed ID: 34704251
[TBL] [Abstract][Full Text] [Related]
45. Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe.
Townsend C; Schulte J; Thorne C; Dominguez KI; Tookey PA; Cortina-Borja M; Peckham CS; Bohannon B; Newell ML;
BJOG; 2010 Oct; 117(11):1399-410. PubMed ID: 20716250
[TBL] [Abstract][Full Text] [Related]
46. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy.
Suy A; Martínez E; Coll O; Lonca M; Palacio M; de Lazzari E; Larrousse M; Milinkovic A; Hernández S; Blanco JL; Mallolas J; León A; Vanrell JA; Gatell JM
AIDS; 2006 Jan; 20(1):59-66. PubMed ID: 16327320
[TBL] [Abstract][Full Text] [Related]
47. Early-onset preeclampsia appears to discourage subsequent pregnancy but the risks may be overestimated.
Seeho SK; Algert CS; Roberts CL; Ford JB
Am J Obstet Gynecol; 2016 Dec; 215(6):785.e1-785.e8. PubMed ID: 27457117
[TBL] [Abstract][Full Text] [Related]
48. Maternal and fetal outcomes of pancreatitis in pregnancy.
Hacker FM; Whalen PS; Lee VR; Caughey AB
Am J Obstet Gynecol; 2015 Oct; 213(4):568.e1-5. PubMed ID: 26220112
[TBL] [Abstract][Full Text] [Related]
49. Lack of association between maternal periodontal status and adverse pregnancy outcomes: a multicentric epidemiologic study.
Abati S; Villa A; Cetin I; Dessole S; Lugliè PF; Strohmenger L; Ottolenghi L; Campus GG
J Matern Fetal Neonatal Med; 2013 Mar; 26(4):369-72. PubMed ID: 23039761
[TBL] [Abstract][Full Text] [Related]
50. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
[TBL] [Abstract][Full Text] [Related]
51. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
52. Perinatal outcomes among women with bipolar disorder: a population-based cohort study.
Mei-Dan E; Ray JG; Vigod SN
Am J Obstet Gynecol; 2015 Mar; 212(3):367.e1-8. PubMed ID: 25446660
[TBL] [Abstract][Full Text] [Related]
53. Maternal and perinatal consequences of antepartum haemorrhage of unknown origin.
Bhandari S; Raja EA; Shetty A; Bhattacharya S
BJOG; 2014 Jan; 121(1):44-50; discussion 50-2. PubMed ID: 24125550
[TBL] [Abstract][Full Text] [Related]
54. No increased risk of adverse pregnancy outcomes in women with urinary tract infections: a nationwide population-based study.
Chen YK; Chen SF; Li HC; Lin HC
Acta Obstet Gynecol Scand; 2010 Jul; 89(7):882-8. PubMed ID: 20583933
[TBL] [Abstract][Full Text] [Related]
55. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
Short CE; Douglas M; Smith JH; Taylor GP
HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
[TBL] [Abstract][Full Text] [Related]
56. Maternal age and adverse pregnancy outcome: a cohort study.
Khalil A; Syngelaki A; Maiz N; Zinevich Y; Nicolaides KH
Ultrasound Obstet Gynecol; 2013 Dec; 42(6):634-43. PubMed ID: 23630102
[TBL] [Abstract][Full Text] [Related]
57. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
[TBL] [Abstract][Full Text] [Related]
58. Women referred for occupational risk assessment in pregnancy have no increased risk of adverse obstetric outcomes.
Bidstrup SB; Kaerlev L; Thulstrup AM; Bonde JP
Dan Med J; 2015 Aug; 62(8):A5119. PubMed ID: 26239590
[TBL] [Abstract][Full Text] [Related]
59. Outcomes of Latina women in CenteringPregnancy group prenatal care compared with individual prenatal care.
Trudnak TE; Arboleda E; Kirby RS; Perrin K
J Midwifery Womens Health; 2013; 58(4):396-403. PubMed ID: 23855970
[TBL] [Abstract][Full Text] [Related]
60. Combination antiretroviral therapy with protease inhibitors in HIV-infected pregnancy.
Dola CP; Khan R; DeNicola N; Amirgholami M; Benjamin T; Bhuiyan A; Longo S
J Perinat Med; 2011 Nov; 40(1):51-5. PubMed ID: 22044007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
